Q&A with Lead ALCHEMIST Investigator, Dr. Ramaswamy Govindan
Posted: May 27, 2019
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial) is a large umbrella trial evaluating patients with early-stage NSCLC who have...
The Peaks and Valleys in Lung Cancer Therapeutics Research
By Paul A. Bunn Jr., MD
Posted: May 27, 2019
It is indeed an exciting time in lung cancer therapeutics, and we have reasons to be optimistic....
Advocacy & Survivorship
Improving Clinical Trials Through Clinician, Patient Use of Social Media
By DR Camidge
Posted: March 1, 2019
The National Cancer Institute featured a workshop in June 2018 titled “At the Crossroads of Social Media and Clinical...
Meeting News
IASLC 2019 Mesothelioma Meeting Offers Innovative Approach for Rapid Learning
Posted: May 27, 2019
Mesothelioma is a rare tumor with limited treatment options. The upcoming IASLC 2019 Mesothelioma Meeting (July 10-12) in New York City—a first...
